1. Breast cancer and hormone-replacement therapy in the Million Women Study;Lancet,2003
2. Agence Nationale d’Accréditation et d’Evaluation en Santé. Traitements hormonaux substitutifs de la ménopause. Rapport d’orientation 11 mai 2004. Paris: ANAES; 2004.
3. Bundesinstitut für Arzneimittel und Medizinprodukte. Estrogen-und Estrogen-Gestagen-haltige Arzneimittel zur Hormonsubstitution. Available at: http://www.bfarm.de/de/arzneimittel/am_sicher/am_sicher_akt/hrt_bescheid.pdf. Accessed August 31, 2004.
4. Gordon D, Committee of safety Medicines. Further advice on safety of HRT: risk:benefit unfavourable for first-line use in prevention of osteoporosis. Available at: http://www.mca.gov.uk. CEM/CMO/2003/19. Accessed August 31, 2004.